NASDAQ:LIAN LianBio (LIAN) Stock Price, News & Analysis $0.06 0.00 (0.00%) As of 09/23/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About LianBio Stock (NASDAQ:LIAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LianBio alerts:Sign Up Key Stats Today's Range$0.04▼$0.0650-Day Range$0.03▼$0.1152-Week Range$0.27▼$4.99Volume2,000 shsAverage Volume1.04 million shsMarket Capitalization$6.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview LianBio was a clinical-stage biopharmaceutical company focused on developing and commercializing innovative medicines in China and other key Asian markets. The company’s business model centered on partnering with biotechnology and pharmaceutical companies to obtain regional rights to promising therapies and advance them through clinical development, regulatory review and potential commercialization. LianBio’s activities historically spanned several therapeutic areas, including cardiovascular disease, oncology, immunology and other serious conditions with significant unmet medical needs. Its pipeline included internally and partner-developed programs, with development strategies tailored to patients and regulatory requirements in Greater China and selected Asia-Pacific markets. Founded in 2019 with backing from Perceptive Advisors, LianBio was headquartered in Shanghai and operated as a cross-border drug-development platform. Dr. Carsten Brunn served as the company’s president and chief executive officer during its public-company period. LianBio later undertook a strategic restructuring and ceased operating as a publicly traded company, making its historical business and pipeline the primary context for the NASDAQ: LIAN listing.AI Generated. May Contain Errors. Read More Receive LIAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LianBio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LIAN Stock News HeadlinesLianMedical (Formerly Known as LianBio) Announces Completion of Merger Between LianBio and LianMedicalJuly 17, 2026 | finance.yahoo.comMeiraGTx Holdings PLCMay 3, 2025 | marketwatch.comOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast Wall Street's rate-cut bets. Now he's flagging October 7 as a pivotal date for the U.S. dollar. Brown says he warned a top Department of Commerce official directly, on record, that urgency was needed. He notes banks have already booked a reported 22 billion dollar windfall tied to the situation.September 24 at 1:00 AM | Brownstone Research (Ad)China's Zeekr prices US IPO at top of range to raise $441 millionMay 10, 2024 | msn.comExclusive-China's Zeekr prices US IPO at top of range to raise $441 million, source saysMay 9, 2024 | msn.comLianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-MarketFebruary 13, 2024 | markets.businessinsider.comLianBio to Wind Down Operations, Declares Special DividendFebruary 13, 2024 | marketwatch.comLianBio Shares Gain After Co Announces Plans to Wind DownFebruary 13, 2024 | marketwatch.comSee More Headlines LIAN Stock Analysis - Frequently Asked Questions How have LIAN shares performed this year? LianBio's stock was trading at $0.0950 at the beginning of the year. Since then, LIAN shares have decreased by 37.4% and is now trading at $0.0595. How were LianBio's earnings last quarter? LianBio (NASDAQ:LIAN) released its earnings results on Monday, March, 27th. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.10. When did LianBio IPO? LianBio (LIAN) raised $325 million in an initial public offering on the week of November 1st 2021. The company issued 20,300,000 shares at a price of $16.00 per share. Goldman Sachs, Jefferies and BofA Securities acted as the underwriters for the IPO. How do I buy shares of LianBio? Shares of LIAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LianBio own? Based on aggregate information from My MarketBeat watchlists, some other companies that LianBio investors own include Arista Networks (ANET), NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Novo Nordisk A/S (NVO), PACCAR (PCAR) and Super Micro Computer (SMCI). Company Calendar Last Earnings3/27/2023Today9/24/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:LIAN CIK1831283 Webwww.lianbio.com Phone609-486-2308FaxN/AEmployees110Year Founded2019Profitability EPS (Trailing Twelve Months)($0.81) Trailing P/E RatioN/A Forward P/E Ratio0.02 P/E GrowthN/ANet Income-$110.29 million Net MarginsN/A Pretax MarginN/A Return on Equity-33.17% Return on Assets-30.19% Debt Debt-to-Equity RatioN/A Current Ratio10.06 Quick Ratio10.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.71 per share Price / Book0.02Miscellaneous Outstanding Shares108,063,000Free Float99,861,000Market Cap$6.43 million OptionableNot Optionable Beta0.23 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:LIAN) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc. (OTCQB: VDTA) is targeting the layers beneath the AI boom - GPU hardware and financing, man...Trading Wire | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredThe Pentagon Has 120 Days to Solve This Critical Mineral ProblemChina controls roughly 80% of the world's tungsten supply, and new Pentagon sourcing restrictions take effect ...The Tomorrow Investor | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredWall Street Legend: “I've discovered a fatal flaw built into Elon's AI model”Wall Street veteran Marc Chaikin says he's found a fatal flaw built into Elon Musk's AI model and every fronti...Chaikin Analytics | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
